|
SPG21 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.55529999990023E-09 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.92410000002352E-06 |
| Normal-vs-Stage2 |
3.879100E-03 |
| Normal-vs-Stage3 |
1.81149995004404E-09 |
| Normal-vs-Stage4 |
8.10250000427004E-08 |
| Stage1-vs-Stage2 |
7.337000E-01 |
| Stage1-vs-Stage3 |
9.456800E-03 |
| Stage1-vs-Stage4 |
2.770300E-02 |
| Stage2-vs-Stage3 |
1.756440E-01 |
| Stage2-vs-Stage4 |
2.265600E-01 |
| Stage3-vs-Stage4 |
9.457600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.274799486088E-10 |
| Normal-vs-AfricanAmerican |
7.643400E-03 |
| Normal-vs-Asian |
9.320200E-01 |
| Caucasian-vs-AfricanAmerican |
3.906600E-01 |
| Caucasian-vs-Asian |
1.211590E-01 |
| AfricanAmerican-vs-Asian |
3.496600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.26410010131895E-11 |
| Normal-vs-Female |
2.784600E-04 |
| Male-vs-Female |
1.918420E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.577900E-03 |
| Normal-vs-Age(41-60Yrs) |
6.11880000001008E-08 |
| Normal-vs-Age(61-80Yrs) |
6.20750000290826E-08 |
| Normal-vs-Age(81-100Yrs) |
6.01239999999947E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.457800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.946400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.988600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.285800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.475600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.990800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.482800E-01 |
| Normal-vs-Grade 2 |
2.3462999998447E-07 |
| Normal-vs-Grade 3 |
4.66420000400092E-08 |
| Normal-vs-Grade 4 |
1.01919999995204E-06 |
| Grade 1-vs-Grade 2 |
1.346820E-01 |
| Grade 1-vs-Grade 3 |
1.076020E-01 |
| Grade 1-vs-Grade 4 |
5.643700E-02 |
| Grade 2-vs-Grade 3 |
5.151600E-01 |
| Grade 2-vs-Grade 4 |
9.402300E-02 |
| Grade 3-vs-Grade 4 |
2.583800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.008710E-04 |
| Normal-vs-ccB subtype |
7.26400000150562E-08 |
| ccA subtype-vs-ccB subtype |
3.079600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.89820000051633E-07 |
| Normal-vs-N1 |
6.322500E-02 |
| N0-vs-N1 |
7.160200E-01 |
|
|
